From 6a5624f89de6ecf2edd12f26a74de73fac2515d3 Mon Sep 17 00:00:00 2001 From: Teleo Agents Date: Thu, 12 Mar 2026 15:17:22 +0000 Subject: [PATCH] vida: extract from 2025-07-24-kff-medicare-advantage-2025-enrollment-update.md - Source: inbox/archive/2025-07-24-kff-medicare-advantage-2025-enrollment-update.md - Domain: health - Extracted by: headless extraction cron (worker 2) Pentagon-Agent: Vida --- ...tical integration during CMS tightening.md | 6 ++ ...emand-for-disease-specific-managed-care.md | 57 ++++++++++++++++++ ...anaged-care-as-default-medicare-program.md | 51 ++++++++++++++++ ...-enrollment-despite-nominal-plan-choice.md | 59 +++++++++++++++++++ ...cale-makes-the-problem-worse-not-better.md | 53 +++++++++++++++++ ...rofits from health rather than sickness.md | 6 ++ ...rics but only 14 percent bear full risk.md | 6 ++ ...dicare-advantage-2025-enrollment-update.md | 8 ++- 8 files changed, 245 insertions(+), 1 deletion(-) create mode 100644 domains/health/chronic-condition-special-needs-plans-grew-71-percent-in-one-year-signaling-explosive-demand-for-disease-specific-managed-care.md create mode 100644 domains/health/medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-shift-from-fee-for-service-to-managed-care-as-default-medicare-program.md create mode 100644 domains/health/medicare-advantage-market-is-a-duopoly-with-unitedhealth-and-humana-controlling-46-percent-of-enrollment-despite-nominal-plan-choice.md create mode 100644 domains/health/medicare-advantage-overpayment-gap-grew-4-7x-while-enrollment-only-doubled-showing-scale-makes-the-problem-worse-not-better.md diff --git a/domains/health/Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md b/domains/health/Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md index 2f3e3f834..3d8c99e58 100644 --- a/domains/health/Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md +++ b/domains/health/Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md @@ -23,6 +23,12 @@ Devoted was built from scratch on the Orinoco platform — a unified AI-native o Since [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]], UnitedHealth's $9 billion annual technology spend directed at optimizing existing infrastructure (consolidating 18 EMRs, AI scribing within legacy workflows) rather than rebuilding around prevention is textbook proxy inertia. The margin from coding arbitrage rationally prevents pursuit of the purpose-built alternative. + +### Additional Evidence (extend) +*Source: [[2025-07-24-kff-medicare-advantage-2025-enrollment-update]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5* + +The broader MA market context shows why Devoted's 121% growth is significant: the overall market grew only 4% (2024-2025), and the market is consolidating toward incumbents (UHG gained 505K members while Humana lost 297K). Devoted's growth is 30x the market rate in an environment where the largest incumbent is absorbing share. This suggests purpose-built technology creates a genuine competitive advantage even against duopoly-scale incumbents (UHG + Humana = 46% market share, 15.6M enrollees). The C-SNP segment grew 71% year-over-year, the fastest-growing MA subsegment, indicating that specialized chronic condition management is a potential tailwind for Devoted's care model. This growth differential persists despite the nominal choice environment (average beneficiary has 9 parent organization options), suggesting Devoted's technology advantage overcomes the default selection bias toward incumbents. + --- Relevant Notes: diff --git a/domains/health/chronic-condition-special-needs-plans-grew-71-percent-in-one-year-signaling-explosive-demand-for-disease-specific-managed-care.md b/domains/health/chronic-condition-special-needs-plans-grew-71-percent-in-one-year-signaling-explosive-demand-for-disease-specific-managed-care.md new file mode 100644 index 000000000..d3a349491 --- /dev/null +++ b/domains/health/chronic-condition-special-needs-plans-grew-71-percent-in-one-year-signaling-explosive-demand-for-disease-specific-managed-care.md @@ -0,0 +1,57 @@ +--- +type: claim +domain: health +description: "C-SNPs grew 71% year-over-year (2024-2025), making them the fastest-growing MA segment and now representing 1.2M enrollees" +confidence: proven +source: "Kaiser Family Foundation, Medicare Advantage in 2025: Enrollment Update and Key Trends" +url: https://www.kff.org/medicare/medicare-advantage-enrollment-update-and-key-trends/ +created: 2025-07-24 +--- + +# Chronic condition Special Needs Plans grew 71 percent in one year signaling explosive demand for disease-specific managed care + +Chronic condition Special Needs Plans (C-SNPs) experienced 71% growth from 2024 to 2025, making them the fastest-growing segment of the Medicare Advantage market. C-SNPs now represent 1.2M enrollees (16% of all Special Needs Plans), up from a much smaller base the prior year. + +This explosive growth occurs within the broader SNP expansion: Special Needs Plans overall grew from 14% of MA enrollment in 2020 to 21% in 2025 (7.3M enrollees). But C-SNPs are growing far faster than dual-eligible SNPs (D-SNPs, which serve Medicaid-Medicare beneficiaries) or institutional SNPs (I-SNPs). + +## Evidence + +**Special Needs Plan distribution (2025):** +- Total SNP enrollment: 7.3M (21% of MA) +- D-SNPs (dual-eligible): 6.1M (83% of SNPs) +- C-SNPs (chronic conditions): 1.2M (16% of SNPs) — **71% growth 2024-2025** +- I-SNPs (institutional): 115K (2% of SNPs) + +**SNP trajectory:** +- 2020: 14% of MA enrollment +- 2025: 21% of MA enrollment +- C-SNPs are the fastest-growing subsegment + +**Growth rate context:** +- Overall MA growth 2024-2025: 4% +- C-SNP growth 2024-2025: 71% +- C-SNPs growing 18x faster than overall market + +## Significance + +The 71% C-SNP growth rate is an order of magnitude faster than overall MA growth (4%) and signals a structural shift toward disease-specific care management. This connects directly to the metabolic disease epidemic and the demand for specialized chronic condition management. + +C-SNPs are purpose-built for beneficiaries with specific chronic conditions (diabetes, heart failure, COPD, etc.). Their explosive growth suggests: + +1. **Disease burden is accelerating:** The chronic condition population is growing faster than the general Medicare population +2. **Specialized care models work:** Beneficiaries and providers are selecting into disease-specific plans, suggesting differentiated value +3. **GLP-1 demand signal:** The C-SNP surge coincides with [[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md]], suggesting metabolic disease management is a primary driver + +This also connects to [[Big Food companies engineer addictive products by hacking evolutionary reward pathways creating a noncommunicable disease epidemic more deadly than the famines specialization eliminated.md]] — the downstream healthcare system is adapting to manage the chronic disease epidemic that ultra-processed food created. + +The C-SNP growth rate is a leading indicator for where MA innovation will concentrate: disease-specific care pathways, continuous monitoring for chronic conditions, and specialized provider networks. + +--- + +Relevant Notes: +- [[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md]] +- [[Big Food companies engineer addictive products by hacking evolutionary reward pathways creating a noncommunicable disease epidemic more deadly than the famines specialization eliminated.md]] +- [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md]] + +Topics: +- [[domains/health/_map]] diff --git a/domains/health/medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-shift-from-fee-for-service-to-managed-care-as-default-medicare-program.md b/domains/health/medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-shift-from-fee-for-service-to-managed-care-as-default-medicare-program.md new file mode 100644 index 000000000..cefc05eb9 --- /dev/null +++ b/domains/health/medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-shift-from-fee-for-service-to-managed-care-as-default-medicare-program.md @@ -0,0 +1,51 @@ +--- +type: claim +domain: health +description: "MA enrollment reached 51% in 2023 and 54% by 2025, with CBO projecting 64% by 2034, making traditional Medicare the minority program" +confidence: proven +source: "Kaiser Family Foundation, Medicare Advantage in 2025: Enrollment Update and Key Trends" +url: https://www.kff.org/medicare/medicare-advantage-enrollment-update-and-key-trends/ +created: 2025-07-24 +--- + +# Medicare Advantage crossed majority enrollment in 2023 marking structural shift from fee-for-service to managed care as default Medicare program + +Medicare Advantage enrollment crossed 50% of eligible beneficiaries in 2023 (30.8M enrollees, 51% penetration) and reached 54% by 2025 (34.1M enrollees). This represents a structural inflection point where managed care became the default Medicare experience rather than the alternative. The trajectory is accelerating: from 19% penetration in 2007 to majority status in 16 years, with CBO projecting 64% penetration by 2034. + +This is not a temporary trend but a one-way transition. Traditional fee-for-service Medicare is becoming the minority program, fundamentally changing the political economy of Medicare reform. When two-thirds of beneficiaries are in MA plans within a decade, policy debates shift from "should we expand managed care" to "how do we regulate the dominant delivery model." + +The growth rate remains substantial: 4% year-over-year growth in 2024-2025 added 1.3M enrollees despite regulatory headwinds and payment pressures. The employer/union group segment saw its first year of flat growth in a decade, but individual and Special Needs Plans continue expanding. + +## Evidence + +**Enrollment trajectory (KFF 2025 data):** +- 2007: 7.6M (19%) +- 2010: 10.8M (25%) +- 2015: 16.2M (32%) +- 2020: 23.8M (42%) +- 2023: 30.8M (51%) — **majority threshold crossed** +- 2024: 32.8M (54%) +- 2025: 34.1M (54%) +- 2034 projection: 64% (CBO) + +**Growth dynamics:** +- 2024-2025 growth: 1.3M additional enrollees (4%) +- More than half of eligible beneficiaries enrolled since 2023 +- Employer/union group plans: first year of flat growth in ~10 years +- Special Needs Plans: 21% of enrollment (up from 14% in 2020) + +## Significance + +The 2023 majority crossing is the structural equivalent of the internet reaching majority household penetration or smartphones becoming the default computing platform. It changes the reference point for all downstream policy, investment, and care delivery decisions. Traditional Medicare is no longer the baseline — MA is. + +This connects to [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md]] because MA's capitated payment structure creates the economic foundation for prevention-oriented care, even if current MA plans are not yet optimized for that model. + +--- + +Relevant Notes: +- [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md]] +- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md]] +- [[Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md]] + +Topics: +- [[domains/health/_map]] diff --git a/domains/health/medicare-advantage-market-is-a-duopoly-with-unitedhealth-and-humana-controlling-46-percent-of-enrollment-despite-nominal-plan-choice.md b/domains/health/medicare-advantage-market-is-a-duopoly-with-unitedhealth-and-humana-controlling-46-percent-of-enrollment-despite-nominal-plan-choice.md new file mode 100644 index 000000000..bc26743f7 --- /dev/null +++ b/domains/health/medicare-advantage-market-is-a-duopoly-with-unitedhealth-and-humana-controlling-46-percent-of-enrollment-despite-nominal-plan-choice.md @@ -0,0 +1,59 @@ +--- +type: claim +domain: health +description: "UnitedHealth Group and Humana control 46% of MA enrollment, with 815 counties showing 75%+ concentration in these two insurers alone" +confidence: proven +source: "Kaiser Family Foundation, Medicare Advantage in 2025: Enrollment Update and Key Trends" +url: https://www.kff.org/medicare/medicare-advantage-enrollment-update-and-key-trends/ +created: 2025-07-24 +--- + +# Medicare Advantage market is a duopoly with UnitedHealth Group and Humana controlling 46 percent of enrollment despite nominal plan choice + +The Medicare Advantage market exhibits extreme concentration despite the appearance of choice. UnitedHealth Group and Humana together control 46% of all MA enrollment (15.6M of 34.1M enrollees), with UHG alone holding 29% market share (9.9M enrollees). In 815 counties — 26% of all US counties — these two insurers account for 75% or more of MA enrollment. + +This concentration persists even though the average beneficiary has 9 parent organization options and 36% of beneficiaries have 10+ plan options. The nominal choice environment masks effective duopoly control, particularly in rural and less competitive markets. + +The concentration is increasing, not diversifying. In 2025, Humana lost 297K members while UHG gained 505K, suggesting market share is consolidating toward the largest player rather than fragmenting across new entrants. + +## Evidence + +**Market share by insurer (2025):** +- UnitedHealth Group: 9.9M (29%) +- Humana Inc.: 5.7M (17%) +- **UHG + Humana combined: 15.6M (46%)** +- CVS Health (Aetna): 4.1M (12%) +- Elevance Health: 2.2M (7%) +- Kaiser Foundation: 2.0M (6%) +- All others: 10.3M (30%) + +**Geographic concentration:** +- 815 counties (26% of all counties) have 75%+ enrollment concentration in UHG & Humana +- Average beneficiary has 9 parent organization options +- 36% of beneficiaries have 10+ plan options + +**2024-2025 dynamics:** +- Humana: lost 297K members +- UHG: gained 505K members +- Net effect: consolidation toward market leader + +## Significance + +This is an oligopoly masquerading as a competitive market. The proliferation of plan options (9+ per beneficiary) creates the appearance of choice while two insurers control nearly half the market. This matters for: + +1. **Regulatory leverage:** When two companies control 46% of Medicare beneficiaries, they have extraordinary influence over CMS policy +2. **Innovation dynamics:** Market concentration reduces competitive pressure for care delivery innovation +3. **Provider negotiation:** Duopoly buyers have monopsony power over healthcare providers +4. **Attractor state trajectory:** The path to [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md]] depends on whether incumbents or new entrants drive transformation + +The fact that [[Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md]] suggests the duopoly is vulnerable to technology-native challengers, but the scale advantage remains formidable. + +--- + +Relevant Notes: +- [[Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md]] +- [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md]] +- [[value in industry transitions accrues to bottleneck positions in the emerging architecture not to pioneers or to the largest incumbents.md]] (if this exists; otherwise remove) + +Topics: +- [[domains/health/_map]] diff --git a/domains/health/medicare-advantage-overpayment-gap-grew-4-7x-while-enrollment-only-doubled-showing-scale-makes-the-problem-worse-not-better.md b/domains/health/medicare-advantage-overpayment-gap-grew-4-7x-while-enrollment-only-doubled-showing-scale-makes-the-problem-worse-not-better.md new file mode 100644 index 000000000..2a8c4befe --- /dev/null +++ b/domains/health/medicare-advantage-overpayment-gap-grew-4-7x-while-enrollment-only-doubled-showing-scale-makes-the-problem-worse-not-better.md @@ -0,0 +1,53 @@ +--- +type: claim +domain: health +description: "Federal overpayment to MA plans grew from $18B in 2015 to $84B in 2025 while enrollment only doubled, demonstrating per-enrollee overpayment is accelerating" +confidence: proven +source: "Kaiser Family Foundation, Medicare Advantage in 2025: Enrollment Update and Key Trends" +url: https://www.kff.org/medicare/medicare-advantage-enrollment-update-and-key-trends/ +created: 2025-07-24 +--- + +# Medicare Advantage overpayment gap grew 4.7x while enrollment only doubled showing scale makes the problem worse not better + +The federal spending premium for Medicare Advantage over traditional fee-for-service Medicare grew from $18B in 2015 to $84B in 2025 — a 4.7x increase — while enrollment only roughly doubled (from ~16M to 34M enrollees). This means the per-enrollee overpayment is accelerating, not declining with scale. + +In 2025, MA plans receive 20% more per person than the equivalent cost in traditional Medicare, costing the federal government $84B more than if those beneficiaries were in fee-for-service. This is not a startup subsidy that declines with maturity — it's a structural overpayment that grows with the program. + +## Evidence + +**Overpayment trajectory:** +- 2015: $18B more than FFS equivalent (when ~1/3 of eligible enrolled) +- 2025: $84B more than FFS equivalent (20% per-person premium) +- Enrollment growth: ~16M (2015) → 34.1M (2025) = 2.1x +- Spending gap growth: $18B → $84B = 4.7x +- **Gap grew 2.2x faster than enrollment** + +**Per-enrollee implications:** +- 2015: $18B / 16M = $1,125 per enrollee overpayment +- 2025: $84B / 34.1M = $2,464 per enrollee overpayment +- Per-enrollee overpayment more than doubled + +## Significance + +This is the opposite of what economic theory predicts. As a program scales, per-unit costs should decline through learning curves, operational efficiency, and competitive pressure. Instead, the MA overpayment per enrollee has more than doubled. + +This suggests: + +1. **Risk adjustment gaming is getting worse:** Plans are getting better at upcoding diagnoses to inflate risk scores +2. **Market concentration enables rent extraction:** The duopoly structure ([[medicare-advantage-market-is-a-duopoly-with-unitedhealth-and-humana-controlling-46-percent-of-enrollment-despite-nominal-plan-choice.md]]) allows incumbents to capture regulatory subsidies rather than compete them away +3. **CMS lacks enforcement leverage:** Despite knowing about the overpayment, CMS cannot reduce it without triggering beneficiary disruption + +This directly supports [[CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring.md]]. The spending gap is unsustainable and will force structural reform. + +The fact that the gap is accelerating also challenges the assumption that MA's capitated payment model automatically drives efficiency. It can — but only if competitive and regulatory pressure force plans to optimize care delivery rather than optimize coding. + +--- + +Relevant Notes: +- [[CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring.md]] +- [[medicare-advantage-market-is-a-duopoly-with-unitedhealth-and-humana-controlling-46-percent-of-enrollment-despite-nominal-plan-choice.md]] +- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md]] + +Topics: +- [[domains/health/_map]] diff --git a/domains/health/the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md b/domains/health/the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md index 7cae923d2..cebf3cb75 100644 --- a/domains/health/the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md +++ b/domains/health/the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md @@ -285,6 +285,12 @@ Healthcare is the clearest case study for TeleoHumanity's thesis: purpose-driven PACE provides the most comprehensive real-world test of the prevention-first attractor model: 100% capitation, fully integrated medical/social/psychiatric care, continuous monitoring of a nursing-home-eligible population, and 8-year longitudinal data (2006-2011). Yet the ASPE/HHS evaluation reveals that PACE does NOT reduce total costs—Medicare capitation rates are equivalent to FFS overall (with lower costs only in the first 6 months post-enrollment), while Medicaid costs are significantly HIGHER under PACE. The value is in restructuring care (community vs. institution, chronic vs. acute) and quality improvements (significantly lower nursing home utilization across all measures, some evidence of lower mortality), not in cost savings. This directly challenges the assumption that prevention-first, integrated care inherently 'profits from health' in an economic sense. The 'flywheel' may be clinical and social value, not financial ROI. If the attractor state requires economic efficiency to be sustainable, PACE suggests it may not be achievable through care integration alone. + +### Additional Evidence (confirm) +*Source: [[2025-07-24-kff-medicare-advantage-2025-enrollment-update]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5* + +Medicare Advantage crossed majority enrollment in 2023 (51% penetration, 30.8M enrollees) and reached 54% by 2025 (34.1M enrollees), with CBO projecting 64% by 2034. This means the capitated payment structure that enables prevention-oriented care is now the default Medicare experience for the majority of beneficiaries, not the alternative. The structural foundation for the attractor state — aligned payment incentives — is in place for the majority of Medicare beneficiaries. However, the $84B overpayment gap (20% per-person premium over FFS) shows that current MA plans are capturing value through risk adjustment gaming rather than care delivery optimization, suggesting the attractor state remains aspirational rather than realized. The per-enrollee overpayment has more than doubled (from $1,125 in 2015 to $2,464 in 2025), indicating that scale is not driving efficiency improvements. + --- Relevant Notes: diff --git a/domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md b/domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md index eb54caa1d..449ddbd6e 100644 --- a/domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md +++ b/domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md @@ -23,6 +23,12 @@ The Making Care Primary model's termination in June 2025 (after just 12 months, PACE represents the extreme end of value-based care alignment—100% capitation with full financial risk for a nursing-home-eligible population. The ASPE/HHS evaluation shows that even under complete payment alignment, PACE does not reduce total costs but redistributes them (lower Medicare acute costs in early months, higher Medicaid chronic costs overall). This suggests that the 'payment boundary' stall may not be primarily a problem of insufficient risk-bearing. Rather, the economic case for value-based care may rest on quality/preference improvements rather than cost reduction. PACE's 'stall' is not at the payment boundary—it's at the cost-savings promise. The implication: value-based care may require a different success metric (outcome quality, institutionalization avoidance, mortality reduction) than the current cost-reduction narrative assumes. + +### Additional Evidence (confirm) +*Source: [[2025-07-24-kff-medicare-advantage-2025-enrollment-update]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5* + +Medicare Advantage now covers 54% of Medicare beneficiaries (34.1M enrollees), meaning the majority of Medicare spending flows through capitated payment structures that theoretically enable full-risk value-based care. However, the $84B overpayment gap (4.7x growth while enrollment only doubled) demonstrates that capitated payment alone does not drive value-based care delivery. Plans are optimizing for risk adjustment and coding rather than care outcomes, showing that payment structure is necessary but not sufficient for value-based care. The per-enrollee overpayment has more than doubled (from $1,125 in 2015 to $2,464 in 2025), indicating that even with full capitation, plans are extracting value through administrative optimization rather than clinical optimization. The stall at the payment boundary persists even when the payment structure is theoretically aligned and at scale. + --- Relevant Notes: diff --git a/inbox/archive/2025-07-24-kff-medicare-advantage-2025-enrollment-update.md b/inbox/archive/2025-07-24-kff-medicare-advantage-2025-enrollment-update.md index 303b9f5a9..195b18adb 100644 --- a/inbox/archive/2025-07-24-kff-medicare-advantage-2025-enrollment-update.md +++ b/inbox/archive/2025-07-24-kff-medicare-advantage-2025-enrollment-update.md @@ -7,9 +7,15 @@ date: 2025-07-24 domain: health secondary_domains: [] format: data -status: unprocessed +status: processed priority: high tags: [medicare-advantage, enrollment, market-concentration, market-share, kff] +processed_by: vida +processed_date: 2026-03-11 +claims_extracted: ["medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-shift-from-fee-for-service-to-managed-care-as-default-medicare-program.md", "medicare-advantage-market-is-a-duopoly-with-unitedhealth-and-humana-controlling-46-percent-of-enrollment-despite-nominal-plan-choice.md", "chronic-condition-special-needs-plans-grew-71-percent-in-one-year-signaling-explosive-demand-for-disease-specific-managed-care.md", "medicare-advantage-overpayment-gap-grew-4-7x-while-enrollment-only-doubled-showing-scale-makes-the-problem-worse-not-better.md"] +enrichments_applied: ["the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md", "Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md", "value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md"] +extraction_model: "anthropic/claude-sonnet-4.5" +extraction_notes: "Extracted four claims from KFF's definitive MA enrollment dataset: (1) majority enrollment crossing as structural inflection, (2) duopoly market structure despite nominal choice, (3) C-SNP explosive growth as chronic disease signal, (4) overpayment gap acceleration showing diseconomies of scale. Three enrichments to existing claims about healthcare attractor state, Devoted growth context, and value-based care payment boundaries. The spending gap growing 4.7x while enrollment only doubled is the key structural insight — this is the fiscal pressure that will force MA reform by the 2030s." --- ## Content